Skip to content
MedsAcross

Medicine

Triazolam 0.25 mg tablet

Triazolam · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIVGeneric name

Triazolam 0.25 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Triazolam
Brand
Sold under the generic name
Strength
0.25 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 10 tablets and 25 more
Manufacturers
Zydus LifesciencesIndiaBryant Ranch PrepackA-S Medication SolutionsAphena Pharma Solutions - TennesseeIngenus PharmaceuticalsMylan PharmaceuticalsPD-Rx PharmaceuticalsProficient Rx
Origin register
US FDA, United States
Storage
Store at controlled room temperature 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIV
ATC code
N05CD05 Triazolam
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 November 1982
Identifiers
RxCUI 198318, 198317DailyMed set ID f8ca4773-e201-4cb9-8869-5ee07ba1d0bf, ba1d8955-41f8-4b4d-8ed8-e92667e294a1, 97164a9c-4bc7-4f15-829e-5f9e653c7fa5 +7NDC 72789-349, 82804-275, 43353-451 +7Application ANDA214219, NDA017892, ANDA213003

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle70710-1289-1Zydus LifesciencesIndia30 December 2022
500 tablet in 1 bottle70710-1289-5Zydus LifesciencesIndia30 December 2022
10 tablet in 1 bottle70710-1289-8Zydus LifesciencesIndia30 December 2022
100 tablet in 1 bottle70771-1162-1Zydus LifesciencesIndia30 December 2022
500 tablet in 1 bottle70771-1162-5Zydus LifesciencesIndia30 December 2022
10 tablet in 1 bottle70771-1162-8Zydus LifesciencesIndia30 December 2022
100 tablet in 1 bottle, plastic50742-646-01Ingenus Pharmaceuticals20 October 2020
500 tablet in 1 bottle, plastic50742-646-05Ingenus Pharmaceuticals20 October 2020
500 tablet in 1 bottle59762-3718-3Mylan Pharmaceuticals15 November 1982
100 tablet in 1 bottle59762-3718-9Mylan Pharmaceuticals13 January 2017
30 tablet in 1 bottle50090-6471-0A-S Medication Solutions9 May 2023
100 tablet in 1 bottle50090-6471-1A-S Medication Solutions9 May 2023
30 tablet in 1 bottle50090-7787-0A-S Medication Solutions24 November 2025
100 tablet in 1 bottle50090-7787-1A-S Medication Solutions24 November 2025
30 tablet in 1 bottle43353-451-30Aphena Pharma Solutions - Tennessee15 November 1982
60 tablet in 1 bottle43353-451-53Aphena Pharma Solutions - Tennessee15 November 1982
3 tablet in 1 bottle, plastic71335-1876-0Bryant Ranch Prepack29 December 2021
10 tablet in 1 bottle, plastic71335-1876-1Bryant Ranch Prepack29 December 2021
30 tablet in 1 bottle, plastic71335-1876-2Bryant Ranch Prepack8 June 2021
60 tablet in 1 bottle, plastic71335-1876-3Bryant Ranch Prepack29 December 2021
40 tablet in 1 bottle, plastic71335-1876-4Bryant Ranch Prepack29 December 2021
90 tablet in 1 bottle, plastic71335-1876-5Bryant Ranch Prepack29 December 2021
6 tablet in 1 bottle, plastic71335-1876-6Bryant Ranch Prepack29 December 2021
1 tablet in 1 bottle, plastic71335-1876-7Bryant Ranch Prepack3 December 2021
2 tablet in 1 bottle, plastic71335-1876-8Bryant Ranch Prepack7 September 2021
28 tablet in 1 bottle, plastic71335-1876-9Bryant Ranch Prepack29 December 2021
30 tablet in 1 bottle, plastic72789-349-30PD-Rx Pharmaceuticals17 August 2023
30 tablet in 1 bottle, plastic82804-275-30Proficient Rx20 October 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 November 1982Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Triazolam

Clinical summary

Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. It is available as tablets for oral use. MedsAcross supplies Triazolam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Triazolam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Triazolam 0.25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.